Bulk Inquiry
Adomeglivant
- LY2409021- Optical Purity: Optically pure
- Soluble in DMSO
- MF: C32H36F3NO4
- MW: 555.63
Description
Adomeglivant (LY2409021) is a potent, selective, orally administered and competitive human glucagon receptor antagonist with a Ki value of 6.66 nM and more than 200-fold selectivity over related receptors. It is used to study glucagon receptor blockade in glucose homeostasis and diabetes-related models.
Glucagon receptor signaling promotes hepatic glucose output and is an important counter-regulatory pathway in metabolic disease. Adomeglivant is useful for investigating GCGR antagonist pharmacology and type 2 diabetes mechanisms.
Key Features
- Competitive human glucagon receptor antagonist
- Ki: 6.66 nM
- >200-fold selectivity over related receptors
- Orally administered pharmacological profile
Applications
- Glucagon receptor pharmacology
- Type 2 diabetes model research
- Hepatic glucose output studies
- Metabolic disease drug-discovery assays
More Information
| Parent CAS No. | 1488363-78-5 |
|---|---|
| Chemical Name | (S)-3-(4-(1-(4'-tert-Butyl-2,6-dimethylbiphenyl-4-yloxy)-4,4,4-trifluorobutyl)benzamido)propanoic acid |
| SMILES | C1C=C([C@@H](OC2C=C(C)C(C3C=CC(C(C)(C)C)=CC=3)=C(C)C=2)CCC(F)(F)F)C=CC=1C(NCCC(=O)O)=O |&1:3,r| |
| MFCD | N.A. |
| InChi | InChI=1S/C32H36F3NO4/c1-20-18-26(19-21(2)29(20)23-10-12-25(13-11-23)31(3,4)5)40-27(14-16-32(33,34)35)22-6-8-24(9-7-22)30(39)36-17-15-28(37)38/h6-13,18-19,27H,14-17H2,1-5H3,(H,36,39)(H,37,38)/t27-/m0/s1 |
| InChiKey | FASLTMSUPQDLIB-MHZLTWQESA-N |
| CID | 91933867 |
| Short Description | GR antagonist |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1132 | GLP-1 antagonist |
From $165.00 |
| 1907 | GLP-1R agonist DMB |
From $108.90 |
| 2259 | BETP |
From $115.50 |


